Abhijit G Banerjee
Overview
Explore the profile of Abhijit G Banerjee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
114
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saha B, Pallatt S, Banerjee A, Banerjee A, Pathak R, Pathak S
Cells
. 2024 Sep;
13(18.
PMID: 39329744
Highly conformal delivery of radiation therapy (RT) has revolutionized the treatment landscape for primary and metastatic liver cancers, yet concerns persist regarding radiation-induced liver disease (RILD). Despite advancements, RILD remains...
2.
Dil N, Banerjee A
Head Neck Oncol
. 2012 Apr;
4:11.
PMID: 22507529
Background: Oral cancer accounts for roughly 3% of cancer cases in the world with about 350,000 newly reported cases annually and a 5-year survival rate of only 50%. Majority of...
3.
Dil N, Banerjee A
Head Neck Oncol
. 2011 Oct;
3:44.
PMID: 21958730
Background: Oral cancer is the sixth most common malignancy worldwide with a mortality rate that is higher than many other cancers. Death usually occurs as a result of local invasion...
4.
Banerjee A, Gopalakrishnan V, Vishwanatha J
Mol Cell Biochem
. 2007 Jul;
305(1-2):113-21.
PMID: 17636461
Development of oral cancer is clearly linked to the usage of smokeless tobacco. The molecular mechanisms involved in this process are however not well understood. Toward this goal, we investigated...
5.
Banerjee A, Bhattacharyya I, Vishwanatha J
Mol Cancer Ther
. 2005 Jun;
4(6):865-75.
PMID: 15956244
An early interventional effort in oral premalignancy requires novel molecular targets and diagnostic biomarkers to delay or reverse incidences of malignant progression. Microarray-based transcriptional profiling in disease states provides global...
6.
Banerjee A, Bhattacharyya I, Lydiatt W, Vishwanatha J
Cancer Res
. 2003 Nov;
63(22):7769-76.
PMID: 14633702
The small leucine-rich proteoglycan decorin has been associated with negative regulation of cell growth. It has a prominent role in transforming growth factor (TGF)-beta and epidermal growth factor receptor activation...
7.
Banerjee A, Liu J, Yuan Y, Gopalakrishnan V, Johansson S, Dinda A, et al.
Mol Cancer
. 2003 Nov;
2:34.
PMID: 14613585
Background: Prostate cancer (PCa) incidences vary with genetic, geographical and ethnic dietary background of patients while angiogenesis is modulated through exquisite interplay of tumor-stromal interactions of biological macromolecules. We hypothesized...
8.
Gopalakrishnan V, Banerjee A, Vishwanatha J
Pancreatology
. 2003 Aug;
3(4):293-302.
PMID: 12890991
The human FHIT gene is altered or lost in many cancers and FHIT has been shown to be a tumor suppressor. However, the mechanism of tumor suppression by the FHIT...
9.
Vishwanatha J, Swinney R, Banerjee A
Mol Cell Biochem
. 2003 Jul;
248(1-2):67-75.
PMID: 12870656
Smokeless tobacco usage is a growing public health concern in the United States. Epidemiological evidence shows a correlation between use of chewing tobacco, lesions of the oral cavity and the...
10.
Banerjee A, Gopalakrishnan V, Bhattacharya I, Vishwanatha J
Mol Cancer Ther
. 2003 Jan;
1(14):1265-71.
PMID: 12516959
Establishment of an early and reliable biomarker for oral carcinogenesis whose expression can be monitored through noninvasive techniques will enable early diagnosis of cancer. Cyclooxygenases (COXs) have been implicated previously...